Leaders of Yunnan Cell Engineering Center Co., Ltd. visited Shenzhen Cell Valley
First of all, accompanied by Wei Zheng, Assistant chairman of the board, Luan Zhshi, director of the office, and Li Rongyou, Vice minister of quality Management Department, Chairman Ma Bo and General Manager Liu Xin visited the smart exhibition hall, production workshop and R&D laboratory, and initially understood the strategic layout, team strength, core technology, product pipeline and quality control of Shenzhen Cell Valley.
At the symposium, the two sides discussed the development status and market demand of the cell industry, scientific research and clinical applications.
Chairman Shi Yuanyuan introduced in detail the industrial production advantages and advanced cell preparation technology of our company through the use of core technology - retroviral vector. Shi Yuan said that the next 20 years is the era of cell therapy, and the application of non-genetically modified immune cells (such as high-purity, high-amplification NK cells, γδT cells, etc.) will also become an important pillar of clinical treatment of major diseases, and will attract much attention in cancer prevention and control, anti-aging, and improving immune function.
Chairman Ma Bo highly recognized our company's technological breakthroughs and contributions in clinical treatment such as cancer, and introduced Yunnan Cell Engineering Center Co., Ltd. through the introduction of domestic leading cell quality detection and uation technology. Five centers sharing cell storage, preparation, quality testing and uation, health and medical product application and physical examination, and cell industry innovation achievements transformation have been jointly established with professional companies in Yunnan Province, which is a technology sharing platform that can provide a full range of services for the complete cell industry chain.
The two sides indicated that they will actively seek opportunities for the cooperation and development of the cell industry, build a cell therapy development platform, promote the integration and innovation of the cell industry of the two places, and jointly provide patients with more high-quality, accurate and efficient medical services.
Take a group photo